Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Amarin Corp Ads (AMRN)

4.93   0.04 (0.82%) 06-18 08:11
Open: 4.89 Pre. Close: 4.89
High: 4.98 Low: 4.83
Volume: 2,423,652 Market Cap: 1,946M
Amarin Corporation plc, a pharmaceutical company, develops and commercializes therapeutics for the treatment of cardiovascular diseases in the United States. The company's lead product is Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It is also involved in developing REDUCE-IT for the treatment of patients with high triglyceride levels who are also on statin therapy for elevated low-density lipoprotein cholesterol levels. The company sells its products principally to wholesalers and specialty pharmacy providers through direct sales force. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, and eicosapentaenoic acid. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.982 - 5.007 5.007 - 5.032
Low: 4.773 - 4.798 4.798 - 4.824
Close: 4.889 - 4.929 4.929 - 4.97

Technical analysis

as of: 2021-06-17 4:42:03 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 5.91     One year: 6.90
Support: Support1: 4.50    Support2: 4.16
Resistance: Resistance1: 5.06    Resistance2: 5.91
Pivot: 4.77
Moving Average: MA(5): 4.94     MA(20): 4.70
MA(100): 5.88     MA(250): 5.67
MACD: MACD(12,26): 0.04     Signal(9): -0.02
Stochastic oscillator: %K(14,3): 79.16     %D(3): 83.35
RSI: RSI(14): 56.10
52-week: High: 9.25  Low: 3.36  Change(%): -28.7
Average Vol(K): 3-Month: 419003  10-Days: 270406

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
AMRN has closed below upper band by 26.5%. Bollinger Bands are 54.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to AMRN's normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 29 Apr 2021
Amarin (AMRN) Q1 Earnings Top, Vascepa Sales Hit by COVID-19 - Yahoo Finance

Mon, 26 Apr 2021
Is AMRN Stock A Buy or Sell? - Yahoo Finance

Thu, 08 Apr 2021
Amarin Corporation plc (NASDAQ:AMRN) Shares Could Be 43% Below Their Intrinsic Value Estimate - Yahoo Finance

Tue, 09 Mar 2021
Did Amarin Corporation plc (NASDAQ:AMRN) Insiders Buy Up More Shares? - Yahoo Finance

Wed, 17 Feb 2021
Amarin to Report Fourth Quarter and Full Year 2020 Results and Host Conference Call on February 25, 2021 - Yahoo Finance

Fri, 08 Jan 2021
Amarin Corporation plc's (NASDAQ:AMRN) About To Shift From Loss To Profit - Yahoo Finance

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 395
Shares Float (M) 358
% Held by Insiders 1.18
% Held by Institutions 38.97
Shares Short (K) 26,000
Shares Short P. Month (K) 21,980

Stock Financials

EPS 0.002
EPS Est This Year -0.210
EPS Est Next Year -0.060
Book Value (p.s.) 1.610
Profit Margin 0.15
Operating Margin 0.51
Return on Assets (ttm) 0.2
Return on Equity (ttm) 0.2
Qtrly Rev. Growth -8.3
Gross Profit (p.s.) 1.223
Sales Per Share 1.523
EBITDA (p.s.) 0.013
Qtrly Earnings Growth
Operating Cash Flow (M) -45
Levered Free Cash Flow (M) -37

Stock Valuations

PE Ratio 2465.00
PEG Ratio
Price to Book value 3.06
Price to Sales 3.24
Price to Cash Flow -43.65

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.